Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives

doi:10.3748/wjg.14.7021

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4384)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

337

HTML

3647

Figures (1-1)

249

Tables (1-1)

151

Sum=4384

Dec 14, 2008 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Dec 14, 2008; 14(46): 7021-7032
Published online Dec 14, 2008. doi: 10.3748/wjg.14.7021

Open in New Tab Full Size Figure Download Figure

Figure 1 Major growth factor receptor signaling pathways. TK: Tyrosine kinase; P: Phosphorylation; MEK: Mitogen-activated protein kinase; ERK: Extracellular signal-regulated kinase; PI3K: Phosphatidylinositol-3 kinase; mTOR: Mammalian target of rapamycin; JAK: Janus kinase; STAT: Signal transducer and activator of transcription.

Citation: Höpfner M, Schuppan D, Scherübl H. Targeted medical therapy of biliary tract cancer: Recent advances and future perspectives. World J Gastroenterol 2008; 14(46): 7021-7032
URL: https://www.wjgnet.com/1007-9327/full/v14/i46/7021.htm
DOI: https://dx.doi.org/10.3748/wjg.14.7021